Why the study?
Chronic kidney disease is a frequent comorbidity in heart failure patients affecting prognosis, but the relationship between kidney function and adverse kidney events preceding death required investigation.
In heart failure patients, kidney function notably declines and adverse kidney events like AKI and ESKD are common in the year preceding death, especially in those with lower baseline eGFR.
Answers are grounded in this paper and cite their sources.
ESKD rates rise markedly with lower baseline eGFR near death in HF; leaves open whether targeted interventions modify trajectories.
AIMS: Chronic kidney disease is a frequent comorbidity in heart failure (HF) patients, affecting prognosis and mortality. This study investigates the relationship between kidney function and adverse kidney events preceding death in HF patients. METHODS AND ESKD occurred in 0.7% (0.6-0.9), 2.6% (2.4-2.8), and 35.5% (34.3-36.7) of patients in the respective eGFR categories. In the last 3 months before death, kidney function notably declined, with increased chronic kidney replacement therapy. Factors associated with higher adverse kidney events included younger age, male sex, in-hospital death, and greater frailty. CONCLUSIONS: In HF patients, AKI and ESKD are common in the last year of life, particularly in those with lower baseline eGFR, with kidney decline accelerating in the final months.
No takes yet. Share an insight, caveat, or question.
Zahir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: